CClinicalTrials.gg
CompletedNCT05264844Updated Feb 2, 2023

Peripheral Venous Catheter and Masking Tape

An interventional study of Masking tape in Personal Satisfaction, Pain and Comfort, sponsored by Necmettin Erbakan University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-02-02.

Sponsored by Necmettin Erbakan University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

urpose: This study will be carried out to determine the effect of two different catheter covers on the comfort, satisfaction, pain level of the patient and the satisfaction of the nurse.

Materials and Methods: This study, which is planned as an open-label randomized controlled post-test study, will be carried out between December 2021 and February 2022. Data; Descriptive Properties will be collected with the Information Form and Visual Analog Scale (Visual Analog Scale-VAS). Data will be collected face to face by researchers.

Read the detailed description

Peripheral venous catheter (PVK) is applied to patients who apply to the hospital due to outpatient chemotherapy and need to receive treatment by intravenous route. This application is carried out by nurses. During their education, nurses receive theoretical and practical training on PVC applications. Nurses; They are the primary health professionals who are responsible for determining the PVC site, deciding on the catheter number to be used, applying the correct technique, performing the recommended intravenous (IV) interventions, following the complications that may develop by performing the necessary controls, ensuring the continuity of the application and providing catheter care.

The effective application of interventions such as transfusion of intravenous fluids, chemotherapy drugs, blood and blood products, and total parenteral feeding in cancer patients is provided by PVK. The application of PVC is a necessity for the treatment of the individual receiving treatment and may cause pain, deterioration in comfort and dissatisfaction. Although the widespread use of peripheral venous catheters provides great benefits, it has been reported that undesirable events such as phlebitis, infiltration, obstruction, leakage, and rarely infection occur when applied incorrectly and inadequately. In order for peripheral venous catheters to be used effectively in treatment, it is important to fix them with the correct technique. Detection becomes more important in the use of chemotherapy agents. The patches used for fixation adhere to the glove and are difficult to remove from the patient's skin. Therefore, both the nurse and the patient feel discomfort. For this reason, it would be appropriate to use a material that can be easily torn off with a glove, does not adhere to the glove, and fixes the patient's catheter well. This product should also be able to be easily removed without harming the patient's skin.

02

Conditions studied

  • Personal Satisfaction
  • Pain
  • Comfort

Keywords

  • Peripheral venous catheter
  • chemotherapy
  • patch
  • fixation
03

In context

Lead sponsor

Necmettin Erbakan University is the lead sponsor of 198 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being between the ages of 18-65
  • Being open to communication and cooperation
  • Being conscious and able to answer questions
  • Volunteering for research
  • Being receiving chemotherapy treatment with a peripheral venous catheter

Exclusion criteria

Exclusion Criteria:

  • Having a disease that may affect the ability to make decisions (dementia, psychological disorders, etc.)
  • Having sensory losses such as vision and hearing
  • Being in terminal period
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    masking tape group

    Masking tape will be used

    Other: Masking tape

  • No intervention
    standard catheter dressing group

    Medical plaster to be used (It is routine practice in the clinic.)

Interventions

  • OtherMasking tape

    IV catheters will be fixed with masking tape

06

What researchers measure

Primary outcomes

  1. Pain level

    To be evaluated with "Visual analog scale"

    Time frame: a week

  2. Patient comfort

    To be evaluated with "Visual analog scale"

    Time frame: a week

  3. Nurse's practice satisfaction

    To be evaluated with "Visual analog scale"

    Time frame: a week

07

Study locations

1 site
  • Necmettin Erbakan Univercity
    Konya, 42370, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05264844
Lead sponsor
Necmettin Erbakan University
Collaborators
Necmettin Erbakan Üniversiity
Responsible party
Rukiye Burucu (Principal Investigator, Necmettin Erbakan University) — Principal investigator
First posted
Mar 3, 2022
Start date
May 1, 2022
Primary completion
Aug 1, 2022
Completion
Sep 20, 2022
Last update
Feb 2, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion